﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Thu, 16 Apr 2026 02:04:19 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/February-2020/rss/2004</link><atom:link href="http://www.pharmacist.com/Publications/Pharmacy-Today/February-2020/rss/2004" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Inpatient Insights]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/inpatient-insights-33</link><description><![CDATA[ Pharmacy-based transition of care improves patient satisfaction, lowers readmission rates 

   

 Patients who received focused care and education from pharmacists while transitioning out of the ...]]></description><pubDate>Fri, 07 Feb 2020 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/inpatient-insights-33</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2562]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[CRISPR: A potential paradigm shift  in the fight against cancer]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/crispr-a-potential-paradigm-shift-in-the-fight-against-cancer</link><description><![CDATA[  Joey Sweeney, PharmD, BCPS  

   

 Cancer. The diagnosis is terrifying and is often viewed as a death sentence. Most people valiantly fight against this disease, and some prevail. ...]]></description><pubDate>Tue, 07 Jan 2020 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/crispr-a-potential-paradigm-shift-in-the-fight-against-cancer</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2559]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Polypharmacy dangerous to patients with heart failure]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/polypharmacy-dangerous-to-patients-with-heart-failure</link><description><![CDATA[  Maria G. Tanzi, PharmD  

   

 Heart failure (HF)–exacerbating medications are commonly used in older adults hospitalized for HF and are often continued or even initiated after ...]]></description><pubDate>Fri, 07 Feb 2020 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/polypharmacy-dangerous-to-patients-with-heart-failure</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2558]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Reassess safe practices to avoid PCA-by-proxy events]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/reassess-safe-practices-to-avoid-pca-by-proxy-events</link><description><![CDATA[  Maria Tanzi, PharmD  

   

 A recent event of patient-controlled analgesia (PCA) by proxy—a term used to describe conditions under which someone other than the patient administers one or more ...]]></description><pubDate>Fri, 07 Feb 2020 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/reassess-safe-practices-to-avoid-pca-by-proxy-events</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2560]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[DOACs may be an option for VTE prophylaxis in acutely ill hospitalized patients]]></title><link>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/doacs-may-be-an-option-for-vte-prophylaxis-in-acutely-ill-hospitalized-patients</link><description><![CDATA[  Aina Abell  

 In October 2019, FDA approved rivaroxaban (Xarelto—Janssen) for venous thromboembolism (VTE) prophylaxis in acutely ill hospitalized patients at risk of forming blood clots but not ...]]></description><pubDate>Fri, 07 Feb 2020 17:00:00 GMT</pubDate><guid>http://www.pharmacist.com/Publications/Pharmacy-Today/Article/doacs-may-be-an-option-for-vte-prophylaxis-in-acutely-ill-hospitalized-patients</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2561]]></dc:identifier></item></channel></rss>